Mariantonietta Di Salvatore
Overview
Explore the profile of Mariantonietta Di Salvatore including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
180
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mariotti S, Minuti G, Landi L, Bria E, Carlucci G, Di Salvatore M, et al.
Heliyon
. 2024 Dec;
10(23):e39324.
PMID: 39687089
Small-Cell Lung Cancer (SCLC) accounts for 15 % of all lung cancer cases. Due to comorbidities and its aggressive behaviour, patients are highly symptomatic even at a non-metastatic stage. Standardizing...
2.
Vitale A, Mastrantoni L, Russo J, Giacomini F, Giannarelli D, Duranti S, et al.
JCO Precis Oncol
. 2024 Oct;
8:e2400297.
PMID: 39374480
Purpose: The clinical and research FPG500 program (ClinicalTrials.gov identifier: NCT06020625) is currently ongoing at the Fondazione Policlinico Universitario Agostino Gemelli IRCCS to tailor matched targeted therapies (MTTs) according to biomarkers...
3.
Vita E, Monaca F, Milardi D, Mastrantoni L, Stefani A, Vergani E, et al.
Cancer
. 2024 Mar;
130(15):2611-2620.
PMID: 38549441
Background: It is reported that treatment with anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors (TKIs) induces hypogonadism both in male patients with ALK-positive cancer and in murine models. Methods: In...
4.
Pannunzio S, Di Bello A, Occhipinti D, Scala A, Messina G, Valente G, et al.
Front Oncol
. 2024 Jan;
13:1288695.
PMID: 38239635
Squamous cell carcinoma of the head and neck is a complex group of diseases that presents a challenge to the clinician. The prognosis in the recurrent/metastatic disease is particularly dismal,...
5.
Vita E, Stefani A, Piro G, Mastrantoni L, Cintoni M, Cicchetti G, et al.
Cancer Immunol Immunother
. 2023 Sep;
72(11):3803-3812.
PMID: 37668709
Background: Only few ES-SCLC patients experience long-term survival benefit by maintenance IT. Adipokines-induced metabolic meta-inflammation has been related to enhanced responsiveness to IT in obese patients; however, their prognostic role...
6.
Minuti G, Stefani A, Trodella L, Antonini Cappellini G, Cecere F, Dionisi F, et al.
Recenti Prog Med
. 2023 Jul;
114(7):414-425.
PMID: 37392104
Small cell lung cancer (SCLC) represents one of the most complex challenges in the oncological field, with a very slow advancement in research, contrary to the rapid evolutionary of the...
7.
Stefani A, Piro G, Schietroma F, Strusi A, Vita E, Fiorani S, et al.
Front Oncol
. 2022 Nov;
12:1026020.
PMID: 36387232
Lung cancer is one of the most aggressive malignancies, classified into two major histological subtypes: non-small cell lung cancer (NSCLC), that accounts for about 85% of new diagnosis, and small...
8.
Cicala C, Monaca F, Giustiniani M, Di Salvatore M
BMJ Case Rep
. 2022 Mar;
15(3).
PMID: 35351763
Among liver vascular tumours, hepatic small vessel neoplasm (HSVN) has been recently identified as a rare infiltrative vascular neoplasm whose malignant potential is yet to be fully ascertained. About 30...
9.
Ferrara M, Stefani A, Pilotto S, Carbone C, Vita E, Di Salvatore M, et al.
Front Oncol
. 2022 Jan;
11:792385.
PMID: 35004317
Non-small cell lung cancer (NSCLC) represents the perfect paradigm of 'precision medicine' due to its complex intratumoral heterogeneity. It is truly characterized by a range of molecular alterations that can...
10.
Corbingi A, Metafuni E, Di Salvatore M, Putzulu R, Chiusolo P, Schinzari G, et al.
J Clin Apher
. 2021 Nov;
37(1):65-69.
PMID: 34822725
Background: Germ cell tumors represent, among solid cancers, a potentially curable disease even if up to 20% to 30% of patients (pts) relapse after first-line treatment especially considering intermediate and...